These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36731873)

  • 1. Risk factors associated with COVID-19 in systemic lupus erythematosus: Results from a longitudinal prospective cohort.
    Patil A; Shobha V; Shenoy P; S C; Kumar S; Daware M; Haridas V; Janardana R; Pinto B; Kodishala C; Ramaswamy S; S N; Jain V; Singh YP; Singhai S; C S; Jois R; Rao VK; Dharmapalaiah C; Kn S; Balebail D
    Lupus; 2023 Apr; 32(4):560-564. PubMed ID: 36731873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort.
    Mok CC; Tse SM; Chan KL; Ho LY
    Lupus; 2018 Apr; 27(5):722-727. PubMed ID: 29087260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of low-dose glucocorticoid use and infection occurrence in systemic lupus erythematosus patients: a prospective cohort study.
    Abe K; Ishikawa Y; Kita Y; Yajima N; Inoue E; Sada KE; Miyawaki Y; Yoshimi R; Shimojima Y; Ohno S; Kajiyama H; Ichinose K; Sato S; Fujiwara M
    Arthritis Res Ther; 2022 Jul; 24(1):179. PubMed ID: 35902976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Antibody Isotypes in Systemic Lupus Erythematosus Patients Prior to Vaccination: Associations With Disease Activity, Antinuclear Antibodies, and Immunomodulatory Drugs During the First Year of the Pandemic.
    Sjöwall J; Azharuddin M; Frodlund M; Zhang Y; Sandner L; Dahle C; Hinkula J; Sjöwall C
    Front Immunol; 2021; 12():724047. PubMed ID: 34512651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated extrapolation of long-term outcomes in systemic lupus erythematosus: analysis and simulation of the Hopkins lupus cohort.
    Watson P; Brennan A; Birch H; Fang H; Petri M
    Rheumatology (Oxford); 2015 Apr; 54(4):623-32. PubMed ID: 25234659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for cutaneous disease in systemic lupus erythematosus.
    Hannon CW; McCourt C; Lima HC; Chen S; Bennett C
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007478. PubMed ID: 33687069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
    He F; Luo Q; Lei M; Fan L; Shao X; Hu K; Qin S; Yu N; Cao J; Yang L
    Clin Rheumatol; 2020 Sep; 39(9):2803-2810. PubMed ID: 32725351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroid dose and the risk of opportunistic infection in a national systemic lupus erythematosus cohort.
    Yang SC; Lai YY; Huang MC; Tsai CS; Wang JL
    Lupus; 2018 Oct; 27(11):1819-1827. PubMed ID: 30103646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus.
    Kwon HH; Bang SY; Won S; Park Y; Yi JH; Joo YB; Lee HS; Bae SC
    Lupus; 2018 Sep; 27(10):1644-1651. PubMed ID: 29950160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis in patients with systemic lupus erythematosus-a 37-year longitudinal survey-based study.
    Xiao X; Da G; Xie X; Liu X; Zhang L; Zhou B; Li H; Li P; Yang H; Chen H; Fei Y; Tsokos GC; Zhao L; Zhang X
    J Intern Med; 2021 Jul; 290(1):101-115. PubMed ID: 33259665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients.
    Schioppo T; Argolini LM; Sciascia S; Pregnolato F; Tamborini F; Miraglia P; Roccatello D; Sinico RA; Caporali R; Moroni G; Gerosa M
    Rheumatology (Oxford); 2022 May; 61(5):1928-1935. PubMed ID: 34352079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid-induced diabetes mellitus in systemic lupus erythematosus patients: analysis from a Malaysian multi-ethnic lupus cohort.
    Shaharir SS; Gafor AH; Said MS; Kong NC
    Int J Rheum Dis; 2015 Jun; 18(5):541-7. PubMed ID: 25294584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
    Sultan SM; Ioannou Y; Isenberg DA
    Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort.
    Saxena A; Guttmann A; Masson M; Kim MY; Haberman RH; Castillo R; Scher JU; Deonaraine KK; Engel AJ; Belmont HM; Blazer AD; Buyon JP; Fernandez-Ruiz R; Izmirly PM;
    Lancet Rheumatol; 2021 Aug; 3(8):e585-e594. PubMed ID: 34075358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 and Systemic Lupus Erythematosus.
    Thanou A; Sawalha AH
    Curr Rheumatol Rep; 2021 Jan; 23(2):8. PubMed ID: 33511495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes.
    Rúa-Figueroa I; López-Longo FJ; Del Campo V; Galindo-Izquierdo M; Uriarte E; Torre-Cisneros J; Vela P; Tomero E; Narváez J; Olivé A; Freire M; Salgado E; Andreu JL; Martínez-Taboada V; Calvo-Alén J; Hernández-Cruz B; Raya E; Quevedo V; Expósito Pérez L; Fernández-Nebro A; Ibañez M; Pascual-Valls È; Rúa-Figueroa D; Naranjo A; Pego-Reigosa JM
    J Rheumatol; 2020 Feb; 47(2):234-240. PubMed ID: 30988123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year.
    Ramirez GA; Argolini LM; Bellocchi C; Moroni L; Della-Torre E; Farina N; Caporali RF; Beretta L; Gerosa M; Bozzolo EP; Dagna L;
    Clin Immunol; 2021 Oct; 231():108845. PubMed ID: 34478882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of COVID-19 among unvaccinated and vaccinated patients with systemic lupus erythematosus: a general population study.
    Jiang X; Sparks J; Wallace Z; Deng X; Li H; Lu N; Xie D; Wang Y; Zeng C; Lei G; Wei J; Zhang Y
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 36889799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
    Pablos JL; Galindo M; Carmona L; Lledó A; Retuerto M; Blanco R; Gonzalez-Gay MA; Martinez-Lopez D; Castrejón I; Alvaro-Gracia JM; Fernández Fernández D; Mera-Varela A; Manrique-Arija S; Mena Vázquez N; Fernandez-Nebro A; ;
    Ann Rheum Dis; 2020 Dec; 79(12):1544-1549. PubMed ID: 32796045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic lupus erythematosus and risk of infection.
    Barber MRW; Clarke AE
    Expert Rev Clin Immunol; 2020 May; 16(5):527-538. PubMed ID: 32478627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.